AbCellera to Collaborate with Biogen to Discover ...

AbCellera Announces Multi-Target Partnership Agreement with a ...

AbCellera, a technology leader in therapeutic antibody discovery from natural immune repertoires, today announced a multi-target and multi-year ...

Case study on AbCellera. Build with Axial… - Medium

AbCellera is an emerging antibody discovery company led by Carl Hansen, a professor at the University of British Columbia. Formed around his ...

AbCellera Partners with Viking Global Investors for New Antibody ...

AbCellera collaborates with Viking Global Investors and ArrowMark ... Biogen (BIIB). Key Takeaways. AbCellera (ABCL) collaborates with ...

News By Company | AbCellera News on T-Net

AbCellera · AbCellera and Pharma Giant Eli Lilly Expand Collaboration to Develop Antibody Medicines · AbCellera Reports Q1 2024 Business Results: Total Revenue ...

BIIB Biogen Inc. Latest Press Releases - Seeking Alpha

AbCellera to Collaborate with Biogen to Discover Therapeutic Antibodies for Neurological Conditions. Business WireMon, Mar. 11. New Biomarker Data Add Further ...

Teva and AbCellera enter into agreement to discover rare ...

Teva Pharmaceutical Industries and AbCellera have entered into a collaborative research agreement whereby AbCellera will apply its high-throughput single ...

AbCellera's First Program with Regeneron in Multi-Target ...

The partnership, which commenced in March 2020 and allows for four discovery programs selected by Regeneron, leverages AbCellera's antibody ...

AbCellera Announces Presentation on T-cell Engager Platform at ...

AbCellera (NASDAQ:ABCL) announced today that it has expanded its existing multi-target collaboration with Regeneron (NASDAQ:REGN) to discover therapeutic ...

How AbCellera helps partners propel their antibody therapies to the ...

And AbCellera works with larger companies to solve even the most challenging discovery problems to bring programs to the clinic, together. In ...

AbCellera CEO weighs in on AI in antibody drug discovery

Early in the pandemic, AbCellera entered into a partnership with Lilly to co-develop antibody therapies for COVID-19.

Wall Street SWOT: AbCellera stock - Biotech firm's platform shows ...

AbCellera specializes in discovering and developing antibody-based drugs using a proprietary platform that leverages natural immune diversity.

abcellera announces successful completion of collaboration for the

Vancouver, Canada (January 20, 2016) – AbCellera announced today successful completion of its first antibody discovery partnership with MassBiologics of the ...

AbCellera and Lilly to Co-develop Antibody Therapies for the ...

AbCellera is a privately held company that engages in partnerships to discover and develop next-generation therapeutic antibodies. AbCellera's ...

AbCellera Announces Multi-Year Antibody Discovery Collaboration ...

AbCellera will use its world-leading antibody drug discovery platform in a multi-year collaboration to identify antibodies against up to ...

AbCellera and Lilly to Co-develop Antibody Therapies for the ...

The collaboration will leverage AbCellera's rapid pandemic response platform, developed under the DARPA Pandemic Prevention Platform (P3) ...

AbCellera and Empirico Announce Strategic Multi-Target Antibody ...

AbCellera will use its AI-powered antibody discovery technology to search and analyze natural immune responses to identify antibodies with the ...

AbCellera Announces Successful Completion of Collaboration for ...

Through this collaboration AbCellera demonstrated single cell antibody discovery with throughput of millions of cells per experiment, allowing ...

Eli Lilly CEO talks partnering with AbCellera Biologics to co-develop ...

"We're starting this because we believe it could work," Eli Lilly CEO David Ricks told CNBC in explaining the company's partnership with ...

Reimagining biologics: AbCellera and Novartis partner to find new…

The companies will work together to find biologic treatments for up to 10 disease targets. We're excited AbCellera is working with such an esteemed partner.

AbCellera and AbbVie Partner to Advance New Antibody Therapies

... collaboration with AbbVie Inc.. The partnership will leverage AbCellera' s antibody discovery and development engine to deliver optimized ...